Therapeutic dosing of a neuregulin or a fragment thereof for treatment or prophylaxis of heart failure

The invention relates to treatment and prevention of heart failure in a mammal. The invention provides a dosing regimen whereby the therapeutic benefits conferred by administration of peptide comprising an epidermal growth factor-like domain, e.g., a neuregulin such as glial growth factor 2 (GGF2) o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ganguly, Anindita, Parry, Tom, Iaci, Jennifer, Caggiano Anthony O
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Ganguly, Anindita
Parry, Tom
Iaci, Jennifer
Caggiano Anthony O
description The invention relates to treatment and prevention of heart failure in a mammal. The invention provides a dosing regimen whereby the therapeutic benefits conferred by administration of peptide comprising an epidermal growth factor-like domain, e.g., a neuregulin such as glial growth factor 2 (GGF2) or a functional fragment thereof, are maintained and/or enhanced, while concomitantly minimizing any potential side effects.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2020204070BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2020204070BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2020204070BB23</originalsourceid><addsrcrecordid>eNqNjEEKwjAURLtxIeod_sKtUKrg2oriAeq6fOqkDcQk_PyA3t5UPIDMYpjHzCwr000QjshqB3qEZP1IwRCTRxaM2VlPQUo2wuMTXknLAKViClYB65eWECXE6e34ZdN8MYFFybB15WhdLQy7hM3PV9X2eunOtx1i6JEiD_DQ_nRv6lmH-li3bbP_s_YB9dNA8g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Therapeutic dosing of a neuregulin or a fragment thereof for treatment or prophylaxis of heart failure</title><source>esp@cenet</source><creator>Ganguly, Anindita ; Parry, Tom ; Iaci, Jennifer ; Caggiano Anthony O</creator><creatorcontrib>Ganguly, Anindita ; Parry, Tom ; Iaci, Jennifer ; Caggiano Anthony O</creatorcontrib><description>The invention relates to treatment and prevention of heart failure in a mammal. The invention provides a dosing regimen whereby the therapeutic benefits conferred by administration of peptide comprising an epidermal growth factor-like domain, e.g., a neuregulin such as glial growth factor 2 (GGF2) or a functional fragment thereof, are maintained and/or enhanced, while concomitantly minimizing any potential side effects.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220602&amp;DB=EPODOC&amp;CC=AU&amp;NR=2020204070B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220602&amp;DB=EPODOC&amp;CC=AU&amp;NR=2020204070B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Ganguly, Anindita</creatorcontrib><creatorcontrib>Parry, Tom</creatorcontrib><creatorcontrib>Iaci, Jennifer</creatorcontrib><creatorcontrib>Caggiano Anthony O</creatorcontrib><title>Therapeutic dosing of a neuregulin or a fragment thereof for treatment or prophylaxis of heart failure</title><description>The invention relates to treatment and prevention of heart failure in a mammal. The invention provides a dosing regimen whereby the therapeutic benefits conferred by administration of peptide comprising an epidermal growth factor-like domain, e.g., a neuregulin such as glial growth factor 2 (GGF2) or a functional fragment thereof, are maintained and/or enhanced, while concomitantly minimizing any potential side effects.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjEEKwjAURLtxIeod_sKtUKrg2oriAeq6fOqkDcQk_PyA3t5UPIDMYpjHzCwr000QjshqB3qEZP1IwRCTRxaM2VlPQUo2wuMTXknLAKViClYB65eWECXE6e34ZdN8MYFFybB15WhdLQy7hM3PV9X2eunOtx1i6JEiD_DQ_nRv6lmH-li3bbP_s_YB9dNA8g</recordid><startdate>20220602</startdate><enddate>20220602</enddate><creator>Ganguly, Anindita</creator><creator>Parry, Tom</creator><creator>Iaci, Jennifer</creator><creator>Caggiano Anthony O</creator><scope>EVB</scope></search><sort><creationdate>20220602</creationdate><title>Therapeutic dosing of a neuregulin or a fragment thereof for treatment or prophylaxis of heart failure</title><author>Ganguly, Anindita ; Parry, Tom ; Iaci, Jennifer ; Caggiano Anthony O</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2020204070BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2022</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Ganguly, Anindita</creatorcontrib><creatorcontrib>Parry, Tom</creatorcontrib><creatorcontrib>Iaci, Jennifer</creatorcontrib><creatorcontrib>Caggiano Anthony O</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Ganguly, Anindita</au><au>Parry, Tom</au><au>Iaci, Jennifer</au><au>Caggiano Anthony O</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Therapeutic dosing of a neuregulin or a fragment thereof for treatment or prophylaxis of heart failure</title><date>2022-06-02</date><risdate>2022</risdate><abstract>The invention relates to treatment and prevention of heart failure in a mammal. The invention provides a dosing regimen whereby the therapeutic benefits conferred by administration of peptide comprising an epidermal growth factor-like domain, e.g., a neuregulin such as glial growth factor 2 (GGF2) or a functional fragment thereof, are maintained and/or enhanced, while concomitantly minimizing any potential side effects.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU2020204070BB2
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Therapeutic dosing of a neuregulin or a fragment thereof for treatment or prophylaxis of heart failure
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T10%3A23%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Ganguly,%20Anindita&rft.date=2022-06-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2020204070BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true